SIX:GALD

Galderma Group AG · SIX · Healthcare · CHF · FY for 2025

Figures on this page computed 2026-11-08 12:26 UTC

Last close

n/aCHF

Market data

85.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed
- Computed from the filing for 2025
7.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
11.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
19.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
0.34Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed

Price is the furthest below its sector's middle: 0.11 against 0.37 on the market's range.

Five bars, one line

lens 7 of 9

1.21x

5.56x

3.95x

0.64x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.21x
Its own average over 5 years, 4.34B.
Profit5.56x
Its own average over 5 years, 110.3M.
Free cash flow3.95x
Its own average over 5 years, 261.1M.
Debt0.64x
Its own average over 5 years, 4.33B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 5.56 times.

Sales is 1.21 times its own 5-year average; Profit is 5.56 times its own 5-year average; Free cash flow is 3.95 times its own 5-year average; Debt is 0.64 times its own 5-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 5-year average1.21
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Profit against its own 5-year average5.56
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Free cash flow against its own 5-year average3.95
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Debt against its own 5-year average0.64
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
CHF